Codes / ICD10CM / T81.41XS

T81.41XS Infection following a procedure, superficial incisional surgical site, sequela

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Infection Following a Procedure, Superficial Incisional Surgical Site, Sequela (ICD-10 Code: T81.41XS)
  • Also referred to as a superficial incisional surgical site infection sequela.

Summary

This condition describes a late effect (sequela) of a superficial incisional surgical site infection that occurred after a procedure. It represents the residual or chronic state of the infection, which may persist beyond the acute phase and require ongoing management. The infection is confined to the superficial layers of the incision site and is documented as a sequela of the initial event.

Causes

Sequela of a superficial incisional surgical site infection result from incomplete resolution of the initial infection, leading to persistent tissue changes or complications. Contributing factors include inadequate treatment of the acute infection, delayed healing, or underlying patient factors that impede recovery. The infection remains localized to the superficial incision layers.

Risk Factors

  • Delayed or incomplete treatment of the initial infection.
  • Compromised immune system (e.g., due to illness or medications).
  • Chronic conditions like diabetes or obesity.
  • Poor wound care or hygiene post-procedure.
  • Use of non-absorbable sutures or foreign materials.

Symptoms

  • Persistent redness, warmth, or swelling at the incision site.
  • Chronic or recurrent pain beyond expected recovery.
  • Delayed healing or formation of scar tissue.
  • Recurrent drainage or discharge from the site.
  • Systemic signs of infection (e.g., fever) if the sequela becomes active.

Diagnosis

Diagnosis involves a physical examination of the incision site to assess for persistent signs of infection or tissue changes. Clinical history of a prior superficial incisional surgical site infection is essential. Imaging or laboratory tests may be used to rule out deeper involvement or complications, but the focus remains on the superficial layers.

Treatment Options

Treatment depends on the severity of the sequela and may include:

  • Topical or oral antibiotics for residual infection.
  • Wound care to promote healing (e.g., dressings, debridement).
  • Pain management for chronic discomfort.
  • Surgical revision if scar tissue or persistent drainage requires intervention.
  • Monitoring for recurrence or progression.

Prognosis and Follow-Up

Prognosis is generally favorable with appropriate treatment, though chronic symptoms or recurrent infections may occur. Follow-up care focuses on monitoring for resolution, managing pain, and preventing further complications. Regular assessments of the incision site are recommended to ensure healing progresses without issues.

Complications

  • Chronic pain or discomfort at the incision site.
  • Recurrent infection requiring additional treatment.
  • Formation of hypertrophic or keloid scars.
  • Delayed return to normal activities due to persistent symptoms.

Lifestyle & Prevention

  • Maintain good wound hygiene and follow post-procedure care instructions.
  • Monitor the incision site for signs of infection and seek prompt care if symptoms worsen.
  • Manage underlying conditions (e.g., diabetes) to support healing.
  • Avoid activities that strain the incision during recovery.

When to Seek Professional Help

Seek medical attention if:

  • Symptoms (e.g., redness, swelling, pain) worsen or persist beyond expected healing time.
  • Fever, chills, or systemic signs of infection develop.
  • Drainage or discharge from the incision site increases or becomes foul-smelling.
  • The incision fails to heal or shows signs of dehiscence.

Tips for Medical Coders

When coding T81.41XS, ensure the documentation specifies the infection as a sequela of a prior superficial incisional surgical site infection. The code requires clear linkage to the initial event and confirmation that the infection is in the superficial layers. Verify that the sequela is not due to deeper tissue involvement or other complications. Accurate clinical documentation of the residual effects is essential for proper coding.

Book a walkthrough

T81.41XS policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.